Clinical Trial Update: Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction [Phase 3]

View source ↗

Summary

Phase 3 trial update for an oral facial skin lipid pheromone intended to treat opioid addiction appears to be in early or unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Addiction
• Opioid Dependence
• Opioid Use Disorder

Drugs mentioned

• Paternal Pheromone Deficiency (fictitious/unknown name)

Snippet

Sponsor: Bubba Nicholson | Conditions: Opioid Addiction, Opioid Abuse, Continuous Use | Phase 3 | Status: UNKNOWN